关键字: 类型:
下载页码(大于1,小于329):
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 
 药物发现的新方法 872条(本栏目收费,不能显示细节,电话13136136841)
Research use only (RUO) assay, 307 307 
Right ventricular systolic pressure (RVSP),229 229 
RNA biomarkers, 295 295 
RNAi. See Interference RNA (RNAi) 
RNA interference (RNAi) addressing off-target effects, 34–36 34 36 
development, 27 27 
discovery, 27 27 
screening technologies, 30–32 30 32 
plate-based screening, assay performance, hit identification, and statistics, 34 34 
synthetic lethality, 33 33 
types, 27–30 27 30 
workflow, 27, 28 27 28 
Ro5. See Rule of 5 (Ro5) RO2443, 132, 133 132 133 
Rofecoxib, 159 159 
Routine cell culture, 175–176 175 176 
Rule of 5 (Ro5), 44 44 
“Rule of three,” 110 110 
RUO assay. See Research use only (RUO) 
assay 
rWEC. See Rat whole embryonic cell culture 
(rWEC) 
Safety screening, 264, 269 264 269 
Salmonella typhimurium, 265 265 
Sampson hypothesis endometriosis, 197 197 
SAR. See Structure–activity relationships (SAR) Scaffold hopping, 150, 159–162 150 159 162 
Second mitochondrial activator of caspase (SMAC), 128 128 
Serum creatinine (SCr), 290 290 
sGC stimulator. See Soluble guanylate cyclase (sGC) stimulator shRNA dropout screening, 33 33 
Thienodiazepine-type BET inhibitors, 51 51 
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3